Showing results (1-10 of 782) with videos related to

Sort By:
Pageof 79
The Lancet. HIV|July 30, 2016
Low-dose versus standard-dose ritonavir-boosted atazanavir in virologically suppressed Thai adults with HIV (LASA): a randomised, open-label, non-inferiority trialTorsak Bunupuradah, Sasisopin Kiertiburanakul, Anchalee Avihingsanon, et al.
The Lancet. HIV|July 1, 2015
The immediate eff ect of the Same-Sex Marriage Prohibition Act on stigma, discrimination, and engagement on HIV prevention and treatment services in men who have sex with men in Nigeria: analysis of prospective data from the TRUST cohortSheree R Schwartz, Rebecca G Nowak, Ifeanyi Orazulike, et al.
The Lancet. HIV|December 5, 2017
Universal test and treat and the HIV epidemic in rural South Africa: a phase 4, open-label, community cluster randomised trialCollins C Iwuji, Joanna Orne-Gliemann, Joseph Larmarange, et al.
The Lancet. HIV|October 8, 2017
Daily and non-daily pre-exposure prophylaxis in African women (HPTN 067/ADAPT Cape Town Trial): a randomised, open-label, phase 2 trialLinda-Gail Bekker, Surita Roux, Elaine Sebastien, et al.
The Lancet. HIV|October 11, 2017
Efficacy and safety of switching from boosted protease inhibitors plus emtricitabine and tenofovir disoproxil fumarate regimens to single-tablet darunavir, cobicistat, emtricitabine, and tenofovir alafenamide at 48 weeks in adults with virologically suppressed HIV-1 (EMERALD): a phase 3, randomised, non-inferiority trialChloe Orkin, Jean-Michel Molina, Eugenia Negredo, et al.
The Lancet. HIV|July 2, 2016
The HIV prevention cascade: integrating theories of epidemiological, behavioural, and social science into programme design and monitoringJames R Hargreaves, Sinead Delany-Moretlwe, Timothy B Hallett, et al.
The Lancet. HIV|June 7, 2020
Fixed-dose combination bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir-containing regimens for initial treatment of HIV-1 infection: week 144 results from two randomised, double-blind, multicentre, phase 3, non-inferiority trialsChloe Orkin, Edwin DeJesus, Paul E Sax, et al.
The Lancet. HIV|May 31, 2020
Framework for the implementation of advanced HIV disease diagnostics in sub-Saharan Africa: programmatic perspectivesZibusiso Ndlovu, Rosie Burton, Rosanna Stewart, et al.
The Lancet. HIV|May 11, 2020
Raltegravir versus efavirenz in antiretroviral-naive pregnant women living with HIV (NICHD P1081): an open-label, randomised, controlled, phase 4 trialEsaú C João, R Leavitt Morrison, David E Shapiro, et al.
The Lancet. HIV|May 11, 2020
The HIV-1 antibody response: a footprint of the viral reservoir in children vertically infected with HIVPaolo Palma, Margaret McManus, Nicola Cotugno, et al.
Pageof 79